Grant: Project Grant
University of Toronto
$688,500.00
CEACAM-1 and TIM-3 interactions in HIV reservoir establishment, persistence and evasion from HIV specific immunity.
FY 2017-18
Summary
No therapy can yet rid the body of HIV, the virus that causes AIDS, thus requiring life-long adherence to drugs. People on effective therapy harbour residual virus in their bodies, which can remain silent or 'latent' for many years, in areas of the body called 'reservoirs'. The main reservoir of hidden virus is within CD4 cells. It has been estimated that there are only about a million of CD4 cells in the body that contain HIV hidden from the effects of the immune cells. An immune cell called
the 'cytotoxic killer T cell' can attack this reservoir. This proposal will explore new strategies to allow the immune system to 'see' the latent virus better instead of it being hidden and also improve the ability of the immune system to kill HIV infected
cells better and eliminate reliance on drug therapy. Our preliminary findings suggest that two immune molecules called
CEACAM-1 and TIM-3 are key to HIV's ability to hide and evade immune attacks. Our grant proposal aims to increase our
understanding of the effects of these molecules on the reservoir. If successful, these studies will pave the way to new
immune based therapies that can be used so that the immune system can rid the body of HIV. If successful, such treatment
would benefit Canadians living with HIV as it will reduce the burden of lifelong treatments and side effects associated with
them, thus improving their health and well-being.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
371636
Name
Ostrowski Mario A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
CEACAM-1 and TIM-3 interactions in HIV reservoir establishment, persistence and evasion from HIV specific immunity.
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$688,500
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cd4 Cells; Ceacam-1; Ctl; Cytotoxic T Cell; Hiv; Hiv Cure Research; Immune Exhaustion; Immunotherapy; Latency; Tim-3
Abstract
No therapy can yet rid the body of HIV, the virus that causes AIDS, thus requiring life-long adherence to drugs. People on effective therapy harbour residual virus in their bodies, which can remain silent or 'latent' for many years, in areas of the body called 'reservoirs'. The main reservoir of hidden virus is within CD4 cells. It has been estimated that there are only about a million of CD4 cells in the body that contain HIV hidden from the effects of the immune cells. An immune cell called
the 'cytotoxic killer T cell' can attack this reservoir. This proposal will explore new strategies to allow the immune system to 'see' the latent virus better instead of it being hidden and also improve the ability of the immune system to kill HIV infected
cells better and eliminate reliance on drug therapy. Our preliminary findings suggest that two immune molecules called
CEACAM-1 and TIM-3 are key to HIV's ability to hide and evade immune attacks. Our grant proposal aims to increase our
understanding of the effects of these molecules on the reservoir. If successful, these studies will pave the way to new
immune based therapies that can be used so that the immune system can rid the body of HIV. If successful, such treatment
would benefit Canadians living with HIV as it will reduce the burden of lifelong treatments and side effects associated with
them, thus improving their health and well-being.
Competitiondate
201709
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Ostrowski, Mario A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $688,500~ $0~